Tyler Seibert MD PhD
@TylerSbrt
#radonc and #cancer scientist @UCSanDiego. Quantitative MRI. Genetic risk. https://t.co/h6i5eUrPMk
ID:1194496557799763968
http://SeibertLab.com 13-11-2019 06:08:36
12,3K Tweets
2,2K Followers
541 Following
Mark Storey Nat Lester-Coll, MD Priyamvada Maitre Vedang Murthy Great data! Our randomized full vs empty bladder study is about 65% accrued and is a mix of SBrT and moderate hypofrac. We are recording the number of results for bowel or other issues, so stay tuned!
Huge endeavour by ESTRO ESMO - Eur. Oncology to create guidelines for combination of #radiotherapy & new cancer drugs.
Looking forward to full paper. As Dr. David Palma discussed, the toxicity threshold to withhold #radiotherapy (or lower dose) needs to be defined on case by case basis.
Great presentation at #ismrm 2024 in Singapore by Vall d’Hebron Institute of Oncology (VHIO) Radiomics Group 's Anna Voronova -- her new FlowSim simulator enables the estimation of #microvascular properties in #cancer , and may enable the computation of new biomarkers in tumours. Well done Anna!!
Congratulations to @ESTRO Anna Kirby Anthony Chalmers 💙 for a record-breaking, breathtaking, stimulating, earth-shaking #ESTRO2024 . Enjoyed Scotland, the hospitality, the networking, and all the science. 🙏🏽🏴🙏🏽🏴
So proud of Priyanka P who did a fantastic job presenting the results of the TRAP trial at #ESTRO24 , funded by Prostate Cancer UK SBRT can delay time to next therapy (usually chemotherapy in this setting) maintaining QOL. Thanks to collaborators across the UK
Anthony Chalmers 💙 receives the #ESTRO24 Interdisciplinary Award - a life of multidisciplinary collaboration. 👏🏽👏🏽👏🏽🤩 An emotional moment, indeed. ESTRO The Royal College of Radiologists
⚡️SABR for oligoprogressive mCRPC on ARPI
TRAP trial for #ProstateCancer presented by Priyanka Patel
Encouraging results in phase I. Next up: STAR-TRAP phase II RCT
The ICR Alison Tree 💙🇺🇦
PACE-C acute toxicity results: SBRT vs moderate hypofrac #ESTRO24
Alison Tree 💙🇺🇦 ESTRO #radonc #ProstateCancer
#ProstateCancer : Dissemination and availability of minimally invasive treatments to underserved populations. Presentation by SamWashUro UCSFUrology. #AUA24 written coverage by Julian Chavarriaga University of Toronto > bit.ly/3WpiTjP Amer. Urol. Assn.